Citadel Advisors’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $273K | Sell |
13,500
-47,500
| -78% | -$1.06M | ﹤0.01% | 10684 |
|
|
2025
Q4 | $1.17M | Sell |
61,000
-77,700
| -56% | -$1.63M | ﹤0.01% | 7047 |
|
|
2025
Q3 | $3.34M | Sell |
138,700
-42,200
| -23% | -$986K | ﹤0.01% | 5112 |
|
|
2025
Q2 | $3.52M | Sell |
180,900
-26,100
| -13% | -$386K | ﹤0.01% | 4702 |
|
|
2025
Q1 | $2.66M | Buy |
207,000
+81,600
| +65% | +$1.31M | ﹤0.01% | 4981 |
|
|
2024
Q4 | $2.16M | Buy |
125,400
+119,500
| +2,025% | +$2.39M | ﹤0.01% | 5468 |
|
|
2024
Q3 | $133K | Sell |
5,900
-6,300
| -52% | -$144K | ﹤0.01% | 10716 |
|
|
2024
Q2 | $301K | Buy |
12,200
+3,100
| +34% | +$88K | ﹤0.01% | 9125 |
|
|
2024
Q1 | $300K | Sell |
9,100
-19,400
| -68% | -$660K | ﹤0.01% | 9451 |
|
|
2023
Q4 | $1.04M | Sell |
28,500
-6,500
| -19% | -$223K | ﹤0.01% | 6605 |
|
|
2023
Q3 | $1.28M | Buy |
35,000
+3,100
| +10% | +$124K | ﹤0.01% | 6067 |
|
|
2023
Q2 | $1.22M | Sell |
31,900
-5,100
| -14% | -$189K | ﹤0.01% | 6048 |
|
|
2023
Q1 | $1.52M | Sell |
37,000
-5,400
| -13% | -$225K | ﹤0.01% | 5891 |
|
|
2022
Q4 | $1.47M | Sell |
42,400
-6,600
| -13% | -$231K | ﹤0.01% | 6072 |
|
|
2022
Q3 | $1.36M | Sell |
49,000
-85,400
| -64% | -$2.77M | ﹤0.01% | 6351 |
|
|
2022
Q2 | $3.98M | Buy |
134,400
+3,400
| +3% | +$114K | ﹤0.01% | 4222 |
|
|
2022
Q1 | $5.34M | Buy |
131,000
+9,700
| +8% | +$417K | ﹤0.01% | 4045 |
|
|
2021
Q4 | $5.81M | Sell |
121,300
-114,500
| -49% | -$5.14M | ﹤0.01% | 4036 |
|
|
2021
Q3 | $9.77M | Sell |
235,800
-101,200
| -30% | -$4.03M | ﹤0.01% | 3119 |
|
|
2021
Q2 | $15.2M | Sell |
337,000
-72,600
| -18% | -$3.4M | ﹤0.01% | 2445 |
|
|
2021
Q1 | $18.1M | Buy |
409,600
+10,500
| +3% | +$396K | ﹤0.01% | 2098 |
|
|
2020
Q4 | $13.9M | Buy |
399,100
+55,800
| +16% | +$1.57M | ﹤0.01% | 2224 |
|
|
2020
Q3 | $5.95M | Sell |
343,300
-8,000
| -2% | -$139K | ﹤0.01% | 2908 |
|
|
2020
Q2 | $5.77M | Buy |
351,300
+112,500
| +47% | +$1.71M | ﹤0.01% | 2891 |
|
|
2020
Q1 | $2.17M | Sell |
238,800
-143,600
| -38% | -$2.89M | ﹤0.01% | 4015 |
|
|
2019
Q4 | $8.13M | Sell |
382,400
-38,500
| -9% | -$854K | ﹤0.01% | 2455 |
|
|
2019
Q3 | $9.66M | Buy |
420,900
+13,600
| +3% | +$310K | ﹤0.01% | 2258 |
|
|
2019
Q2 | $9.88M | Buy |
407,300
+237,100
| +139% | +$4.88M | ﹤0.01% | 2198 |
|
|
2019
Q1 | $2.21M | Sell |
170,200
-1,300
| -0.8% | -$22.8K | ﹤0.01% | 4299 |
|
|
2018
Q4 | $2.58M | Buy |
171,500
+110,200
| +180% | +$2.85M | ﹤0.01% | 3753 |
|
|
2018
Q3 | $2.41M | Buy |
61,300
+10,000
| +19% | +$451K | ﹤0.01% | 4090 |
|
|
2018
Q2 | $2.52M | Buy |
51,300
+18,000
| +54% | +$1.02M | ﹤0.01% | 3740 |
|
|
2018
Q1 | $1.99M | Buy |
33,300
+23,200
| +230% | +$1.55M | ﹤0.01% | 3741 |
|
|
2017
Q4 | $795K | Sell |
10,100
-29,800
| -75% | -$2.4M | ﹤0.01% | 4981 |
|
|
2017
Q3 | $3.35M | Buy |
39,900
+24,800
| +164% | +$1.76M | ﹤0.01% | 2762 |
|
|
2017
Q2 | $987K | Sell |
15,100
-12,600
| -45% | -$857K | ﹤0.01% | 4094 |
|
|
2017
Q1 | $2.01M | Buy |
+27,700
| New | +$1.82M | ﹤0.01% | 3071 |
|
Other funds holding ADNT
VPM
WP
Citadel Advisors's ADNT Position: Q1 2026 in Review
Citadel Advisors reduced its Adient (ADNT) stake by 15% in Q1 2026, selling an estimated $1.32M and leaving 336,037 shares worth $6.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3854.
Citadel Advisors first reported a position in ADNT in Q4 2016 and has held it in 33 quarters since. The position peaked at $78.5M in Q1 2023. 286 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.
- Citadel Advisors held 336,037 shares of Adient worth $6.79M as of Q1 2026.
- Citadel Advisors sold 59,417 Adient shares in Q1 2026, an estimated $1.32M.
- Adient made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3854 holding.
- Citadel Advisors first reported a position in Adient in Q4 2016 and has held it in 33 quarters since.
- Citadel Advisors's Adient position peaked at $78.5M in Q1 2023.
- 286 funds tracked by Wall St. Rank held Adient as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.